Join Us in Chicago at AUA 2023!

Lynx Dx and the Windy City will blow you away with the next generation of prostate cancer risk prediction.

MyProstateScore 2.0 (MPS2) is a urine test designed to predict the presence of clinically significant prostate cancer (Grade Group ≥2 or Gleason score ≥7) by analyzing a comprehensive array of 18 unique gene transcripts.

Come see us at the American Urological Association’s annual meeting April 28-May 1, 2023 and discover how a 30-second urine sample can give you personalized insights to guide your patients.